- Home
- AVX vs OVID Comparison
AVX vs OVID Comparison
Compare AVX & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVX | OVID |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.2M | 116.8M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | AVX | OVID |
|---|---|---|
| Price | $1.74 | $1.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 132.1K | ★ 1.5M |
| Earning Date | 03-13-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,319,011.00 | ★ $6,610,000.00 |
| Revenue This Year | $530,767.50 | $1,077.56 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 8001.54 | 945.89 |
| 52 Week Low | $1.12 | $0.24 |
| 52 Week High | $25.38 | $2.01 |
Technical Indicators
Market Signals| Indicator | AVX | OVID |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 56.11 |
| Support Level | N/A | $1.59 |
| Resistance Level | N/A | $1.88 |
| Average True Range (ATR) | 0.00 | 0.13 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 73.39 |
Price Performance
Historical ComparisonAbout AVX Avax One Technology Ltd.
AVAX One Technology Ltd is a public company offering investors regulated access to the Avalanche (AVAX) ecosystem. By integrating the reliability of U.S. capital markets with the growth potential of decentralized finance, it seeks to create a bridge between traditional and digital finance. The company focuses on building a digital-asset treasury, fostering innovation, and investing in decentralized financial technologies that benefit from the Avalanche network.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.